Objective: To study the determinants of early and late outcome after coronary artery bypass grafting (CABG) for evolving myocardial infarction. Method: 269 consecutive patients underwent isolated primary or repeat CABG from 1971 to 1992 for evolving myocardial infarction. By institutional policy, these were patients, strictly diagnosed, infarcting either in the cardiac cateterization laboratory, shortly after a previous CABG, or on cardiac intervention waiting lists. At operation, 125 patients were hemodynamically stable, 89 patients in cardiogenic shock 55 patients in cardiopulmonary resuscitation (CPR). Interval between infarct onset and surgical reperfusion ranged from 53 min to 15 h (median, 135 min; 90% between 75 and 360). An internal mammary artery graft (IMA) was used in 81 patients. Cross-sectional follow-up was 100% complete and multivariable analysis was conducted in the hazard function domain. Result: One-month, 1-year and 10-year survival was 86, 84 and 66%, respectively. The 1-year and 10-year survival, stratified by hemodynamic class, was respectively 98 and 77% for the stable patients, 77 and 60% for the patients in shock and 62 and 49% for those undergoing CPR. Shock and CPR were incremental risk factors for early but not late risk. Use of an IMA graft was not a risk factor early or late in either stable or unstable patients. Conclusion: CABG can be performed with acceptable early and long-term risk in selected patients with evolving myocardial infarction, whatever their hemodynamic state. Outcome as regards survival is neither adversely or advantageously affected by choice of bypassing conduit. An evolving myocardial infarction with stable hemodynamics carries a lesser risk than an unstable anginal state with changing ST-segment. © 1997 Elsevier Science B.V.
Introduction
For many years myocardial infarcts were treated supportively. The advent of thrombolysis [2, 12, 13] and isolated groups [6, 23] performing emergency coronary bypass procedures and angioplasty [18] in selected patients, made the medical profession conscious that a more aggressive approach with early reperfusion could reduce infarct size, preserve left ventricular ejection fraction and therefore maybe save lives. The limitations [4] of thrombolytic therapy became also known and surgical revascularization was mandatory and life-saving when percutaneous intraluminal techniques created mechanical obstructions leading to myocardial cell loss and sometimes to circulatory arrest.
The purpose of this study is therefore fourfold: the generation of a risk factor equation structuring the outcome after coronary bypass grafting in patients in evolving myocardial infarction, the quantification of the influence of the hemodynamic preoperative status, with special interest in the late outcome after coronary artery bypass grafting (CABG) in patients in cardiopul-monary resuscitation, the search after a positive or negative incremental value, early or late after surgery, in the use of an internal mammary artery and finally the study of the early and late hazard for death in a patient with an evolving myocardial infarction in comparison to a patient with unstable angina.
Materials and methods

Definitions
The evolving myocardial infarction was defined as a combination of clinical, electrocardiographic and most frequently hemodynamic parameters. These parameters, present at the start of anaesthesia in the operating theatre, were indicative of myocardial cell destruction. Fixed ST-segment changes, unresponsive to intravenous medication and regional wall dysfunctions were mandatory. Emergency CABG resulting from catheterisation or angioplasty procedures with only intermittent STchanges and without any symptom of myocardial cell necrosis was excluded.
The clinical status, stable, cardiogenic shock or cardiopulmonary resuscitation was assessed at the start of anaesthesia. Cardiogenic shock was defined by one of the following criteria: sustained systolic blood pressure less than 80 mmHg, pulmonary capillary wedge pressure more than 18 mmHg, cardiac output indices less than 2 l/m 2 and or evidence of decreased tissue perfusion. The patients classified under cardiopulmonary resuscitation (CPR) were in ventricular fibrillation and unresponsive to repeated electrical defibrillation or developed insufficient arterial pressure for cerebral oxygenation. CPR was usually started when the systolic blood pressures were under 50 mmHg. Patients who had fibrillated and been successfully defibrillated before entry in the operating theatre were not coded under CPR but under the more appropriate status at entry into the theatre.
Patients
Between January, 1971 and January, 1992, 10 013 patients underwent primary or repeat isolated (CABG) at the Cardiac Surgery Department (Appendix A) of the Gasthuisberg University Hospital in Leuven Belgium. Two hundred and sixty-nine patients (2.7%) were in the evolving phase of a myocardial infarction and form the study population. Patients with previous valvular or ventricular aneurysm surgery were excluded as well as patients with current combined cardiac reconstruction (ventricular septal defect, mitral valve reconstruction or ventricular wallrupture).
The operated patients (Table 1 and Table 2 ) went into evolving myocardial infarction during or after the cardiac catheterisation, during or after a percutaneous coronary angioplasty (PTCA). Some patients were on the in-house or out-house waiting list for PTCA or CABG. Others were very shortly (hours) after previous CABG, suffering from a postoperative myocardial infarction and undergoing at repeat CABG a structural change of the grafts. No patients were refused for surgery and some, who were accepted, might have been decerebrated before the start of anesthesia. The distribution of the patients over this very long timeframe was very uneven. Before 1982 only very few patients were treated, from 1982 until 1986 around 15 per year, rising to around 30 per year till 1991 when a decline was noted.
The mean age of the patients was 59.6 9 9 years, stratified by hemodynamic status it was 59.1 9 8 years for the stable patients, 60.69 10 years for those in shock and 59.29 10 years for those in cardiopulmonary resuscitation.
Surgical technique
Preoperative Swan-Ganz and trans-oesophageal echocardiographic monitoring from the start of the surgical procedure, even before draping, have been routine procedures in the acute infarct patient.
The standard surgical approach for all first and for all very early repeat procedures, even in C.P.R., was median sternotomy, arterial and venous cannulation, left ventricular decompression, cooling to 28°C and 1 mg/kg lidoflazine [7, 8] intravenously as myocardial protection. The aorta was only crossclamped for the duration of each single distal anastomosis and only where collateral or antegrade flow was too abundant. All late repeat procedures used femoral artery and vein extracorporeal cannulation if the patients were in CPR.
Extensive use ( Table 3 ) was made of one or both mammary arteries if the hemodynamic state allowed the harvesting, in more recent years it was sometimes done on the extracorporeal circulation.
One hour reperfusion was done in the hope of restoring some of the depleted high energy reserves [9] . Intra-aortic balloonpumps, uni-and bi-ventricular assist devices (HEMOPUMP ® or ABIOMED ® ) and occasionally heart transplantation were used when appropriate to help the patient through intensive care.
Follow-up
The K.U. Leuven Coronary Surgery Data Base [21] is updated by a regular stream of follow-up reports by the referring cardiologists. On top of these informal follow-up reports, an additional cross-sectional followup was conducted between January 1993 and August 1994, with a common closing date for outcomes information set at 1 January 1993. The follow-up was 100% complete for that date (Table 6 ). 
Variables submitted to multi6ariate analysis
In addition to demographic-, patient-, institutionaland surgical variables, these mammary artery variables were submitted to the multivariable analysis: variables describing the number of mammary artery distals and grafts, variables describing the use of any one mammary artery or of the right or of the left to any coronary system and the quality of the vessels in this coronary system, variables describing the use of bilateral mammary artery grafts to a single or to two coronary systems, variables interacting the use of mammary artery grafts with the hemodynamic status of the patient.
Methods of analysis and depiction
The analyses were made parametrically in a time-related manner [5] , a Kaplan -Meier life table analysis [14] is provided for comparison. In the identification of incremental risk factors a P-value of less than 0.05 was required for inclusion of a variable in the final multivariable model.
Results
The 30-day in-hospital and overall in-hospital mortality was 13.8 and 15.6%, respectively (95% confidence limits (CL 95% ) from 10 to 19% and from 12 to 21%, respectively). Stratified by hemodynamic status (stable, shock, CPR) the overall in-hospital mortality was 1.6, 21.3 and 29.1%, respectively (PB0.001).
The mean hospital stay was 18.1915 days (Table 4 ). An intra-aortic balloonpump was placed in 31 patients, a uni-or biventricular assist device [16, 17] in four patients and both also in four patients.
Nine patients underwent during the follow-up study interval a reoperation, in six patients it was an isolated coronary redo procedure (2.9, 3.2, 4.2, 4.6, 4.9 and 7.0 years interval), one patient had a coronary redo procedure (5.2 years interval) followed by a cardiac transplantation (0.6 years interval) and two others needed a cardiac transplantation (0.02 and 0.003 years interval).
The parametric survival of the study population ( Fig.  1 ) at 1, 5 and 10 years was 84, 79 and 66%, respectively. A two-phase hazard function was identified (Fig. 2,  Appendix B) , an early hazard phase active until around month 6 after surgery and a late hazard phase starting at 12 months after surgery and rising for as long as patients were followed. nor a late beneficial effect. This is visualized in the survival stratified by use of at least one internal mammary artery graft (Fig. 4) .
Discussion
The generation of an equation representing the outcome after CABG in patients in e6ol6ing myocardial infarction
The postoperative electrocardiographic, ultrastructural, high energy reserve and infarctsize changes [9] [10] [11] 19, 23] after CABG on patients with exactly the same entry criteria have been described previously and do not form the purpose of this article.
This study is not representative of the complete evolving infarct population. By excluding the patients with mechanical complications as ventricular septal defect, ventricular wall rupture and acute mitral regurgitation, a high risk but low prevalence segment of patients is not studied. Others have recently analysed this fraction [25] . Since most patients had very short ischemic times (Table 2) this study is also not relevant for the patients with long standing or evolved infarcts. Significant salvage of myocardial tissue can only be obtained by reperfusion, provided reperfusion is instituted within the first hours of ischemia [14, 19] . But the patient selection covers the patients, where a possible benefit of revascularization can be obtained. Due to the fact that the coronary anatomy was known in most patients before the onset of infarction, it was possible to obtain very short ischemic intervals. Acute infarcts at home will necessary have longer ischemic times, thereby reducing the possible benefit.
The early phase of the hazard for death after CABG in patients in evolving myocardial infarction is dominated (Table 5 , Appendix C) by the hemodynamic status, the duration of anginal symptoms and the distribution of coronary artery disease. The dominance of these incremental risk factors is validated by the stratification (Fig. 3) of the survival by hemodynamic class. The late hazard phase is dominated by death from concomitant clinical conditions such as treated diabetes, preoperative history of malignancy or noncarotid vascular surgery.
No influence on death by any mode at any time of the use of internal mammary grafts was identified, neither a hazard-increasing effect on the early hazard, With the increased interest in angioplasty [18] and endovascular stenting in these evolving infarcts without mechanical complications, it became necessary to develop an equation allowing patient-specific predictions for alternative treatments.
The 30-day in-hospital mortality of the total study group was 13.8%, but the possible inferences from this value are diluted by differences in hemodynamic condition. The 30-day in-hospital mortality of the stable patients was only 1.6% and this compares very favourably with the 5% in-hospital mortality of the stable patients in the Mid America Heart Institute experience [18] . A similar comparison can be made in the shockgroup with 21 and 44% for the surgical versus angioplasty in-hospital mortality. This kind of comparison is limited by the univariate approach and multivariate equations are therefore needed to help solve this differential therapy problem.
The quantification of the influence of the hemodynamic status
The main determinants of infarct size at a given duration of coronary occlusion are the amount of muscular area at risk, collateral flow and myocardial oxygen consumption during coronary artery occlusion [3] . It is virtually impossible to assess these determinants in the human at the time of the infarct but the hemodynamic consequences are probably the best substitutes. Cardiogenic shock develops when more than 40% of the left ventricle becomes dysfunctional because of ischemia and infarction [15] . Cardiopulmonary resuscitation is initiated when the arterial pressures or the cardiac output are estimated insufficient for cerebral perfusion. This can be valid in the presence of stable ventricular rythms but also if ventricular fibrillation and or electromechanical dissociation create an immediate lethal condition. One patient has twice an acute infarct at surgery, he will only be counted once in the goodness of follow-up. It was interesting that the hemodynamic status was the major determinant of the early outcome, even though this early hazard was active for close to 6 months after the procedure. No more late effects were identified although close to 50% of the patients were followed for more than 4.4 years ( Table 6) .
If the patients in CPR survive the peri-procedural hazard then their survival is very acceptable (Fig. 3) and this makes the challenge of treating these patients rewarding.
The search after an incremental influence on sur6i6al early or late after surgery in the use of an internal mammary artery in patients with e6ol6ing myocardial infarction
Shock reduces severely [24] the flow in internal thoracic arteries, probably due to the excellent vasomotor response of this conduit, but the benefit of the use of a single mammary artery graft to a major vessel [22] dominates the late follow-up, so that surgeons are confronted with the dilemma of choosing between a possible increased early risk versus a possible increased late benefit.
The overall mortality over the whole follow-up interval of the patients with and without at least one mammary artery graft in situ was 18.5 and 25.0% (univariate analysis, P= 0.247) (Fig. 4) .
It is well known that in the non-infarct CABG patient [1, 19, 22] no negative or positive incremental effect on the peri-procedural mortality was found in the use of one mammary artery graft. The multivariate analysis in this infarct CABG cohort could not discover any incremental value in the early hazard phase for death of any of the surgical technique variables.
One of these variables was an interaction variable combining the preoperative status of shock and the use of one internal mammary artery. Of the 35 patients that combined the preoperative hemodynamic status of shock with the use of at least one mammary artery at CABG, 13 (37.1%) died (univariate analysis versus without one mammary artery, P =0.034).
The late hazard phase of death in this study population identified no incremental risk or benefit in the use of one or more internal mammary arteries. There seems to be no reason why the late beneficial effect of the use of at least one internal mammary artery present in the non-infarct CABG patient [1, 20] should not manifest itself if there would be enough patients at risk in the late hazard phase (Table 6) . We therefore think, taking into consideration the usual limitations in the use of an IMA graft, that young patients should get an IMA graft to a major vessel, even if the patient is in cardiogenic shock or CPR. Bilateral IMA grafts should probably only be used in the stable evolving infarct patients.
The comparison of the early and late hazard for death in a patient with an e6ol6ing myocardial infarction 6ersus in a patient with unstable angina
After having established that the early hazard for death after CABG in evolving myocardial infarction and stable hemodynamics was very low, it became important to correlate this information to the current knowledge of the early hazards in patients with different levels of unstable angina. Since no patients with unstable angina were entered into this study it was necessary to study an additional dataset. Using a parametric multivariate time-related equation based on the 9600 primary isolated CABG patients operated at the K.U. Leuven in the same study interval, four different solutions (Fig. 5) were made for a particular low-risk patient (Appendix D) with four different anginal classes: unstable angina, unstable angina with unstable ST-segment in the hours before surgery, an evolving myocardial infarction with stable hemodynamics and an evolving myocardial infarction with shock. The figure suggests non-overlapping CLs for evolving myocardial infarction and shock versus the other three, non-overlapping CLs for unstable angina with unstable ST-segment versus the other three (until after 8 years) and not evident differences between an evolving myocardial infarction with stable hemodynamics and unstable angina. It can therefore be concluded that some unstable angina patients are more at risk for peri-procedural death than some acute infarct patients. Although surgical revascularization should not be the treatment of choice in patients with evolving myocardial infarction, it is feasable, challenging and rewarding in some very high risk patients.
